Molecular Devices Stock Plummets 24 Percent on Lackluster Q2 Report | GenomeWeb

NEW YORK, July 21 (GenomeWeb News) - Shares in Molecular Devices were down 24 percent, or $6.88, to $22.16 in mid-afternoon trading today after the company reported lackluster results for its second quarter.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.